A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer
Public ClinicalTrials.gov record NCT01981122. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-label, Phase 2 Study of Sipuleucel-T With Concurrent Versus Sequential Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer
Study identification
- NCT ID
- NCT01981122
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Dendreon
- Industry
- Enrollment
- 52 participants
Conditions and interventions
Conditions
Interventions
- enzalutamide Drug
- sipuleucel-T Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2013
- Primary completion
- Jun 29, 2017
- Completion
- Jun 29, 2017
- Last update posted
- Oct 23, 2018
2013 – 2017
United States locations
- U.S. sites
- 19
- U.S. states
- 17
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urological Associates of Southern Arizona, P.C. | Tucson | Arizona | 85741 | — |
| USC/Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| The Urology Center of Colorado | Denver | Colorado | 80211 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06520 | — |
| H. Lee Moffitt Cancer and Research Center | Tampa | Florida | 33612 | — |
| Uro Partners/ RMD Clinical Research | Melrose Park | Illinois | 60160 | — |
| Fort Wayne Medical Oncology and Hematology, Lutheran Hospital, Parkview Regional Medical Center | Fort Wayne | Indiana | 46804, 46845 | — |
| Johns Hopkins Medicine - Sidney Kimmel Comprehensive Cancer Center | Baltimore | Maryland | 21231 | — |
| GU Research Network | Omaha | Nebraska | 68130 | — |
| North Shore Hematology/Oncology Associates, P.C. | East Setauket | New York | 11733 | — |
| Associated Medical Professionals of New York, PLLC | Syracuse | New York | 13210 | — |
| Raleigh Hematology Oncology Associates, D.B.A. Cancer Centers of North Carolina | Raleigh | North Carolina | 27607 | — |
| Cleveland Clinic - Taussig Cancer Institute | Cleveland | Ohio | 44195 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Urology Associates, PC | Nashville | Tennessee | 37209 | — |
| Urology of Virginia | Virginia Beach | Virginia | 23462 | — |
| Virginia Mason Medical Center, Virginia Mason Hospital | Seattle | Washington | 98101 | — |
| Northwest Medical Specialties, Rainier Physicians | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01981122, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 23, 2018 · Synced May 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01981122 live on ClinicalTrials.gov.